UTHR vs. BBH

Last updated Jun 24, 2026

UTHR (United Therapeutics Corporation) is a stock, while BBH (VanEck Vectors Biotech ETF) is Health & Biotech Equities fund tracking the MVIS US Listed Biotech 25 Index. Over the past 10 years, UTHR returned 18.22%/yr vs 7.27%/yr for BBH. At a 0.47 correlation, their price movements are largely independent.

Performance

UTHR vs. BBH - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in United Therapeutics Corporation (UTHR) and VanEck Vectors Biotech ETF (BBH). The values are adjusted to include any dividend payments, if applicable.

Returns By Period

In the year-to-date period, UTHR achieves a 11.71% return, which is significantly higher than BBH's 0.83% return. Over the past 10 years, UTHR has outperformed BBH with an annualized return of 18.22%, while BBH has yielded a comparatively lower 7.27% annualized return.

UTHR

• 1D: 1.12%
• 1M: -4.24%
• YTD: 11.71%
• 6M: 6.64%
• 1Y: 90.07%
• 3Y*: 34.77%
• 5Y*: 25.37%
• 10Y*: 18.22%

BBH

• 1D: 0.77%
• 1M: 3.29%
• YTD: 0.83%
• 6M: -0.86%
• 1Y: 27.19%
• 3Y*: 7.34%
• 5Y*: -0.32%
• 10Y*: 7.27%

*Multi-year figures are annualized to reflect compound growth (CAGR)

UTHR vs. BBH - Yearly Performance Comparison

	2026 (YTD)	2025	2024	2023	2022	2021	2020	2019	2018	2017
UTHR United Therapeutics Corporation	11.71%	38.09%	60.46%	-20.93%	28.70%	42.35%	72.33%	-19.12%	-26.39%	3.15%
BBH VanEck Vectors Biotech ETF	0.83%	21.18%	-4.29%	3.94%	-15.25%	11.81%	22.13%	26.34%	-10.70%	16.46%

Correlation

The correlation between UTHR and BBH is 0.50, which is low. Their price movements are largely independent, making them effective diversification partners.

	Correlation
Correlation (1Y) Calculated over the trailing 1-year period	0.50
Correlation (3Y) Calculated over the trailing 3-year period	0.45
Correlation (5Y) Calculated over the trailing 5-year period	0.41
Correlation (10Y) Calculated over the trailing 10-year period	0.46
Correlation (All Time) Calculated using the full available price history since Nov 23, 1999	0.47

Return for Risk

UTHR vs. BBH — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

UTHR

UTHR Risk / Return Rank: 94
UTHR Sharpe Ratio Rank: 87
UTHR Sortino Ratio Rank: 96
UTHR Omega Ratio Rank: 93
UTHR Calmar Ratio Rank: 97
UTHR Martin Ratio Rank: 96

BBH

BBH Risk / Return Rank: 44
BBH Sharpe Ratio Rank: 42
BBH Sortino Ratio Rank: 43
BBH Omega Ratio Rank: 39
BBH Calmar Ratio Rank: 55
BBH Martin Ratio Rank: 41

The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

UTHR vs. BBH - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for United Therapeutics Corporation (UTHR) and VanEck Vectors Biotech ETF (BBH). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.

	UTHR	BBH	Difference
Sharpe ratio: Return per unit of total volatility	1.91	1.42	+0.49
Sortino ratio: Return per unit of downside risk	4.19	2.09	+2.10
Omega ratio: Gain probability vs. loss probability	1.49	1.25	+0.24
Calmar ratio: Return relative to maximum drawdown	8.51	2.59	+5.92
Martin ratio: Return relative to average drawdown	19.15	6.23	+12.92

UTHR vs. BBH - Sharpe Ratio Comparison

The current UTHR Sharpe Ratio is 1.91, which is higher than the BBH Sharpe Ratio of 1.42. The chart below compares the historical Sharpe Ratios of UTHR and BBH, calculated using daily returns over the previous 12 months. A higher Sharpe Ratio indicates better risk-adjusted performance relative to the risk-free rate.

Drawdowns

UTHR vs. BBH - Drawdown Comparison

The maximum UTHR drawdown since its inception was -93.18%, which is greater than BBH's maximum drawdown of -72.70%. Use the drawdown chart below to compare losses from any high point for UTHR and BBH.

Drawdown Indicators

	UTHR	BBH	Difference
Max Drawdown Largest peak-to-trough decline	-93.18%	-72.70%	-20.48%
Max Drawdown (1Y) Largest decline over 1 year	-10.64%	-10.55%	-0.09%
Max Drawdown (3Y) Largest decline over 3 years	-33.00%	-22.74%	-10.26%
Max Drawdown (5Y) Largest decline over 5 years	-33.00%	-39.86%	+6.86%
Max Drawdown (10Y) Largest decline over 10 years	-55.56%	-39.86%	-15.70%
Current Drawdown Current decline from peak	-8.79%	-11.46%	+2.67%
Average Drawdown Average peak-to-trough decline	-35.28%	-20.73%	-14.55%
Ulcer Index Depth and duration of drawdowns from previous peaks	4.72%	4.37%	+0.35%

Volatility

UTHR vs. BBH - Volatility Comparison

The current volatility for United Therapeutics Corporation (UTHR) is 5.81%, while VanEck Vectors Biotech ETF (BBH) has a volatility of 6.15%. This indicates that UTHR experiences smaller price fluctuations and is considered to be less risky than BBH based on this measure. The chart below showcases a comparison of their rolling one-month volatility.

Volatility by Period

	UTHR	BBH	Difference
Volatility (1M) Calculated over the trailing 1-month period	5.81%	6.15%	-0.34%
Volatility (6M) Calculated over the trailing 6-month period	25.97%	14.59%	+11.38%
Volatility (1Y) Calculated over the trailing 1-year period	47.47%	19.30%	+28.17%
Volatility (5Y) Calculated over the trailing 5-year period, annualized	35.06%	21.44%	+13.62%
Volatility (10Y) Calculated over the trailing 10-year period, annualized	35.02%	22.12%	+12.90%

Dividends

UTHR vs. BBH - Dividend Comparison

UTHR has not paid dividends to shareholders, while BBH's dividend yield for the trailing twelve months is around 0.50%.

Position	TTM	2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015
BBH VanEck Vectors Biotech ETF	0.50%	0.51%	0.80%	0.43%	0.47%	0.21%	0.36%	0.34%	0.50%	0.55%	0.30%	0.27%
UTHR United Therapeutics Corporation	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%

Frequently Asked Questions

Can I hold both UTHR and BBH in my portfolio?

UTHR and BBH have a correlation of 0.50, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

Which is riskier, UTHR or BBH?

BBH has higher volatility (6.15%) compared to UTHR (5.81%). In terms of maximum drawdown, UTHR dropped -93.18% vs BBH's -72.70%.

Which has better risk-adjusted returns?

UTHR currently has the higher Sharpe Ratio (1.91 vs 1.42), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.